Project Grant R43AG084385
Award Date
9/25/24
Completion Date
8/31/25
Dollars Obligated
$500K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This federal Project Grant award for $248,999.00 from the National Institute on Aging (CFDA 93.866 Aging Research) aims to increase access to culturally appropriate Alzheimer's disease and related dementia (ADRD) services for Latinx individuals at community health clinics. The key activities include: Validating a survey instrument to measure beliefs affecting intentions to seek ADRD care among Latinx populations. Partnering with 5 community health clinics to characterize individual and...
This federal Project Grant award, valued at $2,399,431 and effective August 1, 2024, is funded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866). The objective is to develop a digital cognitive health resource based on the Boston University Alzheimer's Disease Research Center (BU ADRC) cohort. The grant will leverage the BU ADRC's extensive longitudinal data, including vascular risk factors, biomarkers, and neuropsychological tests, to collect concurrent...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), has awarded a $299,553 Project Grant to Pilltrax Systems LLC to develop an enhanced medication management service for providers caring for African American and Latino older adults at risk of Alzheimer's disease and related dementias (ADRD). The proposed solution will comprise an electronic pill dispenser that sends medication adherence notifications, an adherence assessment tool, and a provider...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the cultural adaptation of a mobile caregiver intervention for Hispanic dementia caregivers. The $356,974 award, spanning from September 2024 to June 2029, aims to assess the needs of Hispanic Alzheimer's and related dementia (ADRD) informal caregivers and develop modifications to the "Brain CareNotes" mobile telehealth application. The goal is to integrate cultural factors that impact...
The federal Project Grant award R61AG089049, funded by the National Institute on Aging's Aging Research program (CFDA 93.866), aims to assess cost and non-cost barriers to the use of novel Alzheimer's disease (AD) and related dementia (ADRD) therapeutics among older Hispanic or Latino adults. The $311,341 grant will support a two-phase project - the first phase will involve semi-structured interviews with Latino adults and patients/caregivers to inform a population-based survey on cost and...
The National Institute on Aging (NIA) awarded Lifebio Inc. a $864,674 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to develop LifeBioTalk, a tablet-based platform that uses a human-like avatar to engage people with Alzheimer's disease and related dementias (ADRD). The funding will support Lifebio in designing a prototype of LifeBioTalk, which will feature six 22-minute audiovisual episodes narrated by a human-like avatar. The platform is intended to promote mental...
The National Institute on Aging (NIA), part of the Department of Health and Human Services National Institutes of Health, awarded a $3.37 million Project Grant to The University of Texas at Arlington to develop an individualized deep connectome framework for Alzheimer's disease and related dementias (ADRD) analysis. The three-year grant, awarded on August 18, 2022 under the NIA's Aging Research program (CFDA 93.866), will support research to discover and identify individualized...
This $300,506 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) aims to develop high-performing, fair, and interpretable large language models (LLMs) to detect Alzheimer's disease (AD) and its precursor stages, such as mild cognitive impairment (MCI), from transcribed unstructured speech samples. The key objectives are to: 1) build LLM-based models for detecting MCI and dementia and explore their use in detecting the earliest preclinical AD stage; 2)...
This federal Project Grant award, valued at $353,391 and issued by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to develop and validate a digital cognitive assessment tool to detect early memory decline associated with Alzheimer's disease (AD) biomarkers in a diverse, representative sample of older adults. The project, led by Brigham & Women's Hospital Inc., will evaluate a "Personal Learning Curve" paradigm that measures changes in participants' ability...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $767,193 to the University of California, Los Angeles (UCLA) to identify undiagnosed Alzheimer's disease (AD) in understudied populations, including Hispanic/Latino and non-Hispanic African American groups. The key products and services to be delivered under this award include: Identifying disease trajectories associated with AD using electronic health record (EHR) data mining and machine...